Previous studies showed that there was a higher incidence of intracerebral hemorrhage (ICH) and deaths associated with ICH in patients with RCC brain metastasis treated with TKIs and delayed wound healing associated with VEGF inhibition17. This evidence concerns the gene VEGFA and renal cell carcinoma.